CTOs on the Move

Avaxia Biologics

www.avaxiabiologics.com

 
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Continuum Health Services

Continuum Health Services is a Lewiston, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Elizabeth Center for Cancer Detection

The Elizabeth Center for Cancer Detection is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

curasan

curasan is a Attleboro, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CleanCut Technologies

CleanCut Technologies is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aldera

Aldera is the new name for Healthation. Healthation accelerated the business of healthcare. Aldera brings the focus and foresight to improve it. While our name has changed, our solutions remain resilient. Our service remains deeply rooted in customer commitment. The post-healthcare reform landscape is a frontier fraught with challenges. Our expert knowledge of the terrain and our flexible payer platform prepares healthcare payers and administrators to confidently navigate the shifts.